Biotech patent news today?

I can help, but “biotech patent news today” is too broad to answer accurately without knowing what you mean by “today” and which area you care about.

Which one fits best?

1) Pharma/biotech patents involving specific companies (e.g., Pfizer, Moderna, Roche, Amgen, AbbVie)
2) A specific drug or class (e.g., GLP-1s, oncology biologics, biosimilars, mRNA)
3) Patent disputes/court cases (where companies are suing or defending patents)
4) Patent expirations and biosimilar/Generic launch timing
5) Your region (US / EU / UK / other)

Reply with the company/drug(s) and the country/jurisdiction (if you know it), and I’ll summarize the most relevant patent news and what it means. If you want, paste links you’re looking at (or headlines), and I’ll extract the key facts.